Chugai Pharmaceutical

(OTC) CHGCY

Current Price$23.33

Market Cap$76.79B

Since IPO (2010)+664%

5 Year+30%

1 Year-8%

1 Month-5%

Chugai Pharmaceutical Financials at a Glance

Market Cap

$76.79B

Revenue (TTM)

¥1.36T

Net Income (TTM)

¥475.36B

EPS (TTM)

$0.91

P/E Ratio

25.63

Dividend

$0.89

Beta (Volatility)

0.52 (Low)

Dividend

$0.89

Beta (Volatility)

0.52 (Low)

Price

$23.33

Volume

168,679

Open

$23.82

Price

$23.33

Volume

168,679

Open

$23.82

Previous Close

$23.33

Daily Range

$23.17 - $24.00

52-Week Range

$19.50 - $34.84

Estimated Earnings Date

Jul 24, 2026

Dividend

$0.89

Beta (Volatility)

0.52 (Low)

Price

$23.33

Volume

168,679

Open

$23.82

Previous Close

$23.33

Daily Range

$23.17 - $24.00

52-Week Range

$19.50 - $34.84

Estimated Earnings Date

Jul 24, 2026

CHGCY News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Chugai Pharmaceutical

Industry

Pharmaceuticals

Sector

Health Care

Employees

7,872

CEO

Osamu Okuda

Website

www.chugai-pharm.co.jp

Headquarters

Tokyo, 103-8324, JP

CHGCY Financials

Key Financial Metrics (TTM)

Gross Margin

71%

Operating Margin

48%

Net Income Margin

35%

Return on Equity

24%

Return on Capital

32%

Return on Assets

20%

Earnings Yield

3.90%

Dividend Yield

3.79%

Payout Ratio

99.07%

Stock Overview

Market Cap

$76.79B

Shares Outstanding

3.29B

Volume

168.68K

Avg. Volume

258.48K

Financials (TTM)

Gross Profit

¥937.60B

Operating Income

¥618.80B

EBITDA

¥661.98B

Operating Cash Flow

¥408.33B

Capital Expenditure

-¥79.97B

Free Cash Flow

¥328.36B

Cash & ST Invst.

¥980.36B

Total Debt

¥25.73B

Chugai Pharmaceutical Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

¥327.66B

+13.6%

Gross Profit

¥233.16B

+16.2%

Gross Margin

71.16%

N/A

Market Cap

$76.79B

N/A

Market Cap/Employee

$15.28M

N/A

Employees

5,026

N/A

Net Income

¥117.54B

+20.9%

EBITDA

¥174.62B

+27.4%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Total Cash

¥853.78B

-9.6%

Total Debt

¥17.58B

N/A

Accounts Receivable

¥354.47B

+20.3%

Inventory

¥289.54B

+24.2%

Long Term Debt

¥17.58B

N/A

Short Term Debt

¥0.00

N/A

Return on Assets

19.96%

N/A

Return on Invested Capital

31.69%

N/A

Free Cash Flow

¥112.74B

+152.9%

Operating Cash Flow

¥125.67B

+88.5%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

SOAGYSartorius AG

SOAGYSartorius AG$53.48-1.73%

MKGAFMerck KGaA

MKGAFMerck KGaA$155.60-3.44%

MKKGYMerck KGaA

MKKGYMerck KGaA$30.97-2.55%

IPSEYIpsen S.A.

IPSEYIpsen S.A.$46.75+0.00%

HOCPYHOYA Corporation

HOCPYHOYA Corporation$166.85+1.29%

GLAXFGSK plc

GLAXFGSK plc$26.63+0.00%

SEMHFSiemens Healthineers AG

SEMHFSiemens Healthineers AG$39.00-2.74%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

SPCXSpace Exploration Technologies

SPCXSpace Exploration Technologies$160.95+0.19%

AALAmerican Airlines Group

AALAmerican Airlines Group$14.98+0.02%

NOKNokia

NOKNokia$14.80+0.05%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.59+0.04%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$77.52+0.02%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$40.04-0.02%

TSLATesla

TSLATesla$406.43+0.02%

Questions About CHGCY

What is the current price of Chugai Pharmaceutical?

Chugai Pharmaceutical is trading at $23.33 per share.

What is the 52-week range for Chugai Pharmaceutical?

Over the past 52 weeks, Chugai Pharmaceutical has traded between $19.50 and $34.84.

How much debt does Chugai Pharmaceutical have?

As of the most recent reporting period, Chugai Pharmaceutical reported total debt of ¥110.04M.

How much cash does Chugai Pharmaceutical have on hand?

Chugai Pharmaceutical reported ¥2.63B in cash and cash equivalents in its most recent financial results.

What is Chugai Pharmaceutical’s dividend yield?

Chugai Pharmaceutical currently has a dividend yield of 3.79%.

Chugai Pharmaceutical

Chugai Pharmaceutical Financials at a Glance

CHGCY News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Chugai Pharmaceutical

CHGCY Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Chugai Pharmaceutical Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About CHGCY

What is the current price of Chugai Pharmaceutical?

What is the 52-week range for Chugai Pharmaceutical?

How much debt does Chugai Pharmaceutical have?

How much cash does Chugai Pharmaceutical have on hand?

What is Chugai Pharmaceutical’s dividend yield?

Premium Investing Services